Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|September 16, 2015
Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapyLise Cuzin, Pascal Pugliese, Karine Sauné, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2025
Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational studyRomain Palich, Jade Ghosn, Karine Lacombe, et al.
Plos One|October 24, 2024
Facilitating the access to HIV testing at lower costs: "To the laboratory without prescription" (ALSO), a pilot intervention to expand HIV testing through medical laboratories in FranceKaren Champenois, Victoire Sawras, Pamela Ngoh, et al.
The Journal of Infection|June 6, 2017
Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?Pierre Pradat, Pascal Pugliese, Isabelle Poizot-Martin, et al.
AIDS (London, England)|February 14, 2018
Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIVPierre Pradat, Thomas Huleux, François Raffi, et al.
BMC Medicine|December 19, 2017
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to eliminationVictor Virlogeux, Fabien Zoulim, Pascal Pugliese, et al.
Plos One|September 22, 2018
Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patientsClotilde Allavena, Matthieu Hanf, David Rey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2020
Spectrum and Incidence Trends of AIDS- and Non-AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS CohortIsabelle Poizot-Martin, Caroline Lions, Clotilde Allavena, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimenFrançois Raffi, Matthieu Hanf, Tristan Ferry, et al.
Plos One|March 25, 2022
Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in FranceTeresa Rojas Rojas, Isabelle Poizot-Martin, David Rey, et al.
Pageof 5